Avanos Medical (AVNS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 35.5 | 1.92 | 2.40 | -2.30 | -16.9 | -39.1 | ||
| Changes by years, y/y, % | -103% | -95% | +25% | -196% | +634% | -57.1% | |||
Avanos Medical. EV/EBITDA
Avanos Medical. EV/EBITDA, changes, %
Avanos Medical (AVNS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -2.07 | -1.44 | -1.37 | -28.7 | -39.1 | -39.1 | |
| Changes by years, y/y, % | -192% | -184% | -109% | +1 150% | +1 787% | |||
| Changes by quarters, q/q, % | -10% | -30% | -5% | +2 005% | +36% | |||